REQUEST A DEMO
Total
USD $0.00
Search more companies

3SBio Inc. (Hong Kong SAR, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: 3SBio Inc. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

3SBio, Inc. is a pioneer in the biotechnology industry in China. The Company is engaged in developing, manufacturing and marketing biopharmaceuticals, The Company's core products are the following: TPIAO, approved by the CFDA for two indications: the treatment of chemotherapy-induced thrombocytopenia (“CIT”) and the treatment of immune thrombocytopenia (“ITP”); and EPIAO, approved by the CFDA for three indications: the treatment of anemia associated with chronic kidney disease (“CKD”), the treatment of chemotherapy-induced anemia (“CIA”) and the reduction of allogeneic blood transfusion in surgery patients. The Company was incorporated in 2006 and is headquartered in Hong Kong.

Headquarters
No. 3 A1, Road 10, Shenyang Economy And Technology Development Zone
Shenyang; Liaoning;

Contact Details: Purchase the 3SBio Inc. report to view the information.

Website: http://www.3sbio.com

Basic Information
Total Employees:
Purchase the 3SBio Inc. report to view the information.
Outstanding Shares:
Purchase the 3SBio Inc. report to view the information.
Registered Capital:
Purchase the 3SBio Inc. report to view the information.
Financial Auditors:
Purchase the 3SBio Inc. report to view the information.
Incorporation Date:
2006
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Senior Vice President
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
19.55%
Purchase this report to view the information.
18.56%
Purchase this report to view the information.
8.79%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Ample Harvest Investments Limited
100%
Collected Mind Limited
100%
Excel Partner Holdings Limited
100%
Company Performance
Financial values in the chart are available after 3SBio Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
16.01%
Total operating revenue
15.46%
Operating profit (EBIT)
31.92%
EBITDA
12.74%
Net Profit (Loss) for the Period
12.28%
Total assets
3.35%
Total equity
5.71%
Operating Profit Margin (ROS)
4.09%
Net Profit Margin
-0.84%
Return on Equity (ROE)
0.38%
Debt to Equity Ratio
-6.17%
Quick Ratio
-1.11%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?